Laboratory of Evaluation of Human Biological Performance
Thessaloniki, 57001, Greece
NCT Number: NCT05396963
High-intensity functional training (HIFT), a new version of high-intensity interval training, has gained interest in recent years. HIFT is based on the CrossFit training template and includes multijoint movement patterns via both endurance and strengthening exercises. Research has shown positive effects of HIFT on body composition, cardiorespiratory fitness, and muscle performance of young individuals. The effectiveness of HIFT in higher ages and its protein requirements are less well documented. Protein requirements have been widely investigated in resistance training, where it has been found that protein supplementation may have additive beneficial effects on muscle strength and lean body mass. However, there is a research gap regarding the adaptations to HIFT when combined with protein supplementation.
Thus, the aim of this research is to compare the effects of egg white supplementation, whey protein supplementation (as a positive comparator), and maltodextrin (a carbohydrate as placebo) on body composition, physical performance, and plasma amino acid profile in young and middle-aged trained individuals of both sexes who perform HIFT. Participants will take all three supplements for 6 weeks each, with 2 weeks of washout (no supplementation) in between, in random and counterbalanced order. Researchers will not know the supplementation status of the participants. Participants will receive 0.6 g of protein or placebo per kg body weight daily on top of isoenergetic dietary plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day. The HIFT protocol will include multimodal patterns of movement, combining endurance and strengthening exercises with the use of equipment such as Total Resistance eXercise (TRX), Bosu, kettlebells, and barbells.
Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition at the beginning and end of the study, as well as during the two washout periods. Also, plasma amino acids, hematology, biochemistry, and hormones will be measured. Comparison of all these outcome measures between supplements will reveal whether protein supplementation is useful in HIFT.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Thessaloniki, 57001, Greece
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intake of egg white
Intake of whey protein
Intake of maltodextrin
Time frame: Within 2 weeks before the beginning of supplementation.
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Time frame: Within 2 weeks after the end of supplementation.
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Time frame: Within 2 weeks before the beginning of supplementation.
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Time frame: Within 2 weeks after the end of supplementation.
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Time frame: Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Time frame: Within 2 weeks after the end of supplementation.
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Time frame: Within 4 days before the beginning of supplementation.
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Time frame: Within 4 days after the end of supplementation.
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Time frame: Within 2 weeks before the beginning of supplementation.
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Time frame: Within 2 weeks after the end of supplementation.
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Time frame: Within 2 weeks before the beginning of supplementation.
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
Time frame: Within 2 weeks after the end of supplementation.
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
Time frame: Within 4 days before the beginning of supplementation.
Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer.
Time frame: Within 4 days after the end of supplementation.
Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer.
Time frame: Within 4 days before the end of supplementation.
Plasma cortisol and testosterone (both in μg/dL) will be measured by immunoluminescence in an automated analyzer.
Time frame: Within 4 days after the end of supplementation.
Plasma cortisol and testosterone (both in μg/dL) will be measured by immunoluminescence in an automated analyzer.
Time frame: Within 2 weeks before the beginning of supplementation.
Resting metabolic rate will be assessed with indirect calorimetry through the measurement of oxygen consumption with a metabolic analyzer.
Time frame: Within 2 weeks after the end of supplementation.
Resting metabolic rate will be assessed with indirect calorimetry through the measurement of oxygen consumption with a metabolic analyzer.
Time frame: Within the first week of supplementation.
Internal load of exercise will be assessed by telemetric heart rate sensors and software
Time frame: Within the last week of supplementation (week 6).
Internal load of exercise will be assessed by telemetric heart rate sensors and software
Time frame: Within 4 days before the beginning of supplementation
Full blood count will be performed by flow cytometry
Time frame: Within 4 days after the end of supplementation.
Full blood count will be performed by flow cytometry
Time frame: Within 4 days before the beginning of supplementation.
Creatine kinase and γ-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer
Time frame: Within 4 days after the end of supplementation.
Creatine kinase and γ-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer.
Time frame: Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of shoulder muscles will be assessed by a linear encoder.
Time frame: Within 2 weeks after the end of supplementation.
Force-velocity relationship of shoulder muscles will be assessed by a linear encoder.
Time frame: Within 2 weeks before the beginning of supplementation
Maximal grip strength will be assessed by a hand dynamometer
Time frame: Within 2 weeks after the end of supplementation.
Maximal grip strength will be assessed by a hand dynamometer
Aristotle University Of Thessaloniki
Other
Effects of Egg White Supplementation on Body Composition, Physical Performance, and Amino Acid Profile of Individuals Undergoing High-intensity Functional Training
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05849350
Dietary Supplements, Exercise Training
Thessaloniki, Greece
View Trial DetailsNCT05402527
Dietary Supplements, Exercise Training
Thessaloniki, Greece
View Trial DetailsNCT07700550
Exercise Training, Postoperative Recovery
Denizli, Turkey (Türkiye)
View Trial DetailsNCT07207135
Balance, Proprioception, and Functional Performance, Exercise Training
Elâzığ, Merkez, Turkey (Türkiye)
View Trial Details